Indeed, the pathogen seems like ancient history — but as recent developments indicate, tuberculosis isn’t done with us yet.

Australian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine ...

Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including ...

The FDA has authorized an expanded access program that will allow for the use of a recombinant bacillus Calmette-Guerin product.

Metaba, LLC ( and MAX BioPharma, Inc. ( are pleased to announce significant progress in their collaboration to develop ...

INSM posts wider-than-expected Q4 loss. It reiterates its 2025 sales outlook for Arikayce in the range of $405-$425 million.

Tuberculosis (TB) is a serious infectious disease caused by the bacterium Mycobacterium tuberculosis. While multidrug treatment regimens are the standard of care, the lengthy treatment schedule and ...

A simple model projected which strains were likely to be highly transmissible, with implications for public health.

A new study published in Biochemistry sheds light on how bacteria regulate their genes, challenging long-held assumptions ...

While TB cases have been rising nationally in recent years, public health officials continue to emphasize there is no threat ...